compounded semaglutide plan for weight loss | Blog More access to weight loss
Description
Unlike other antihyperglycemic agents, sitagliptin/metformin is associated with little to no hypoglycemia or weight gain
La Raya Pass
doi: 10.1038/s41746-022-00628-3
In early 2026, the FDA and MHRA (UK) reported a spike in unregulated, mass-compounded GLP-1s that were either sub-potent or contained dangerous contaminants
If you're experiencing troublesome side effects, your prescriber will likely suggest: Staying at your current dose longer before increasing Stepping back down to a lower dose temporarily Slowing down the escalation schedule The goal is to find the highest dose you can tolerate comfortably whilst still achieving meaningful weight loss
